Sonographic correlations with the new molecular classification of invasive breast cancer

European Radiology

Volumn 19, Issue 10, 2009, Pages 2342-2348

  Au Yong, I T H ^a   Evans, A J ^a   Taneja, S ^a   Rakha, E A ^b   Green, A R ^b   Paish, C ^b   Ellis, I O ^b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Breast cancer; Breast ultrasound; Molecular classification; Protein expression; Tissue microarray

Indexed keywords

BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MUCIN 1; PROTEIN P53; SMOOTH MUSCLE ACTIN; THYROID HORMONE RECEPTOR BETA; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR PROBE TECHNIQUES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, MAMMARY;

EID: 70349854816     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1418-2     Document Type: Article

References (28)

1. Ellis IO, Galea M, Broughton N et al (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479-89
2. Galea MH, Blamey RW, Elston CW et al (1992) The Nottingham Prognostic Index in primary breast cancer. Br Cancer Res Treat 22:207-219
3. Blamey RW, Ellis IO, Pinder SE et al (2007) Improvement in case survival in breast cancer across the prognostic spectrum: Effect on the Nottingham Prognostic Index. Eur J Cancer 43:1548-1555
4. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19:403-410
5. Carter CL, Allen C, Henson DE (1989) Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63(1):181-187
6. Lee AHS, Pinder SE, Macmillan RD et al (2006) Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 42:357-362
7. Rakha E, Ellis IO (2007) An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol 60(12):1300-1306
8. Tabar L, Duffy SW, Vitak B et al (1999) The natural history of breast cancer - what have we learned from screening? Cancer 86:449-462
9. Alizadeh AA, Ross DT, Perou CM et al (2001) Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195(1):41-52
10. Abd El-Rehim DM, Ball G et al (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116(3):340-350
11. Stavros AT, Thickman D, Rapp CL et al (1995) Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions. Radiology 196:113-123
12. Lamb PM, Perry NM, Vinnicombe SJ et al (2000) Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Rad 55:40-44
13. Kim TH, Kang DK, Kim SY et al (2008) Sonographic differentiation of benign and malignant papillary lesions of the breast. J Ultrasound Med 27:75-82
14. Skaane P, Skjørten F (1999) Ultrasonographic evaluation of invasive lobular carcinoma. Acta Radiol 40(4):369-375
15. Günhan-Bilgen I, Oktay A (2007) Tubular carcinoma of the breast: mammographic, sonographic, clinical and pathologic findings. Eur J Radiol 61(1):158-162
16. Kim SH, Seo BK, Lee J et al (2008) Correlation of ultrasound findings with histology, tumour grade, and biological markers in breast cancer. Acta Oncol Mar 6:1-8
17. Rotstein AH, Neerhut PK (2005) Ultrasound characteristics of histologically proven grade 3 ductal breast carcinoma. Australas Radiol 49:476-479
18. Mesurolle B, Kadoch L, El-Khoury M et al (2007) Sonographic features of breast carcinoma presenting as masses in BRCA gene mutation carriers. J Ultrasound Med 26(6):817-824
19. Schrading S, Kuhl CK (2008) Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology 246(1):58-70
20. Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39(3):305-318
21. Butler RS, Venta LA, Wiley EL et al (1999) Sonographic evaluation of invasive lobular carcinoma. Am J Radiol 172:325-330
22. Sheppard DG, Whitman GJ, Huynh PT et al (2000) Tubular carcinoma of the breast: Mammographic and sonographic features. Am J Radiol 174:253-257
23. Taneja S, Evans AJ, Rakha EA et al (2008) The mammographic correlations of a new immunohistochemical classification of invasive breast cancer. Clin Radiol 63(11):1228-1235
24. Evans AJ, Rakha EA, Pinder SE et al (2007) Basal phenotype: A powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow up. J Med Screen 14(4):210-214
25. Sarriö D, Rodriguez-Pinilla SM, Hardisson D et al (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68(4):989-997
26. Evans AJ, Pinder SE, James JJ et al (2006) Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer. Am J Radiol 187(5):1377-1380
27. Phillips KA (2000) Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. J Clin Oncol 18:107s-112s
28. Tilanus-Linthorst M, Verhoog L, Obdeijn I-M et al (2002) A BRCA 1/2 mutation, high breast density and prominent pushing margins contribute to a frequent false negative mammography. Int J Cancer 102:91-95